Based on the transcriptome profiles of human GBM (Figs 5 and 6), we hypothesized that GBM cell-derived MAP4K1 modulates the expression and secretion of various cytokines and chemokines to retrain the immune responses in the microenvironment of malignant gliomas. The gene discussed is MAP4K1; the disease is malignant glioma.